DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Metaproterenol Sulfate is a drug marketed by Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, Cosette, G And W Labs Inc, Lannett Co Inc, Morton Grove, Am Therap, Heritage Pharma, Par Pharm, Usl Pharma, and Watson Labs. and is included in twenty-nine NDAs.
The generic ingredient in METAPROTERENOL SULFATE is metaproterenol sulfate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metaproterenol sulfate profile page.
A generic version of METAPROTERENOL SULFATE was approved as metaproterenol sulfate by LANNETT CO INC on July 22nd, 1992.